Exact Mass: 395.1025

Exact Mass Matches: 395.1025

Found 39 metabolites which its exact mass value is equals to given mass value 395.1025, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Balaglitazone

5-({4-[(3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione

C20H17N3O4S (395.094)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent Balaglitazone is a selective partial PPARγ agonist with an EC50 of 1.351 μM for human PPARγ.

   
   

4,9,10,11-tetramethoxy-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinolin-8-one|Ocominaron|Ocominarone

4,9,10,11-tetramethoxy-benzo[g][1,3]dioxolo[4,5:4,5]benzo[1,2,3-de]quinolin-8-one|Ocominaron|Ocominarone

C21H17NO7 (395.1005)


   

5-[(6,7-Dimethoxyisoquinolin-1-yl)carbonyl]-1,3-benzodioxole-4-carboxylic acid methyl ester

5-[(6,7-Dimethoxyisoquinolin-1-yl)carbonyl]-1,3-benzodioxole-4-carboxylic acid methyl ester

C21H17NO7 (395.1005)


   

Cys Cys Gly Asn

(2S)-2-{2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanoic acid

C12H21N5O6S2 (395.0933)


   

Cys Cys Asn Gly

2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]acetic acid

C12H21N5O6S2 (395.0933)


   

Cys Gly Cys Asn

(2S)-2-[(2R)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C12H21N5O6S2 (395.0933)


   

Cys Gly Asn Cys

(2R)-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C12H21N5O6S2 (395.0933)


   

Cys Asn Cys Gly

2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]acetic acid

C12H21N5O6S2 (395.0933)


   

Cys Asn Gly Cys

(2R)-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-carbamoylpropanamido]acetamido}-3-sulfanylpropanoic acid

C12H21N5O6S2 (395.0933)


   

Gly Cys Cys Asn

(2S)-2-[(2R)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C12H21N5O6S2 (395.0933)


   

Gly Cys Asn Cys

(2R)-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C12H21N5O6S2 (395.0933)


   

Gly Asn Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C12H21N5O6S2 (395.0933)


   

Asn Cys Cys Gly

2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]acetic acid

C12H21N5O6S2 (395.0933)


   

Asn Cys Gly Cys

(2R)-2-{2-[(2R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-sulfanylpropanamido]acetamido}-3-sulfanylpropanoic acid

C12H21N5O6S2 (395.0933)


   

Asn Gly Cys Cys

(2R)-2-[(2R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C12H21N5O6S2 (395.0933)


   

tert-Butyl ((diphenylphosphoryl)methyl)sulfonylcarbamate

tert-Butyl ((diphenylphosphoryl)methyl)sulfonylcarbamate

C18H22NO5PS (395.0956)


   

K-115

Ripasudil hydrochloride dihydrate

C15H23ClFN3O4S (395.1082)


   

5-[3-(Trifluoroacetamido)-1-(E)-propenyl]-uridine

5-[3-(Trifluoroacetamido)-1-(E)-propenyl]-uridine

C14H16F3N3O7 (395.094)


   

2-AMINO-5,7-DIPHENYL-4,7-DIHYDRO-5H-THIENO[2,3-C]THIOPYRAN-3-CARBOXYLIC ACID EHYL ESTER

2-AMINO-5,7-DIPHENYL-4,7-DIHYDRO-5H-THIENO[2,3-C]THIOPYRAN-3-CARBOXYLIC ACID EHYL ESTER

C22H21NO2S2 (395.1014)


   

dea-c8-18 perfluoroalkylethyl phosphate

dea-c8-18 perfluoroalkylethyl phosphate

C10H20F6NO6P (395.0932)


   

2-(6-{[(3-Chloro-2-Methylphenyl)sulfonyl]amino}pyridin-2-Yl)-N,N-Diethylacetamide

2-(6-{[(3-Chloro-2-Methylphenyl)sulfonyl]amino}pyridin-2-Yl)-N,N-Diethylacetamide

C18H22ClN3O3S (395.107)


   

(2E,6E,10E)-omega-hydroxyfarnesyl diphosphate(3-)

(2E,6E,10E)-omega-hydroxyfarnesyl diphosphate(3-)

C15H25O8P2-3 (395.1025)


   

4-[3-(3-Fluorophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide

4-[3-(3-Fluorophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide

C21H18FN3O2S (395.1104)


   

6-Amino-1,3-dimethyl-5-[(3-methyl-1-phenyl-5-thieno[2,3-c]pyrazolyl)-oxomethyl]pyrimidine-2,4-dione

6-Amino-1,3-dimethyl-5-[(3-methyl-1-phenyl-5-thieno[2,3-c]pyrazolyl)-oxomethyl]pyrimidine-2,4-dione

C19H17N5O3S (395.1052)


   

2-[4-[(4-Chlorophenyl)methoxy]phenyl]-5-(4-morpholinyl)-4-oxazolecarbonitrile

2-[4-[(4-Chlorophenyl)methoxy]phenyl]-5-(4-morpholinyl)-4-oxazolecarbonitrile

C21H18ClN3O3 (395.1037)


   

3-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-(5-methyl-2-thiazolyl)benzamide

3-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-(5-methyl-2-thiazolyl)benzamide

C17H21N3O4S2 (395.0973)


   

2-(Acetylamino)-4-O-[(4,5-didehydro-1-deoxy-beta-D-glucopyranuronic acid)-1-yl]-2-deoxy-D-glucopyranose

2-(Acetylamino)-4-O-[(4,5-didehydro-1-deoxy-beta-D-glucopyranuronic acid)-1-yl]-2-deoxy-D-glucopyranose

C14H21NO12 (395.1064)


   

(2R,3R,4R)-2-[(3R,4R,5R,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

(2R,3R,4R)-2-[(3R,4R,5R,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO12 (395.1064)


   

Delta(4)-beta-D-GlcpA-(1->4)-alpha-D-GlcpNAc

Delta(4)-beta-D-GlcpA-(1->4)-alpha-D-GlcpNAc

C14H21NO12 (395.1064)


   

beta-L-thrHexpA4en-(1->4)-beta-D-GlcpNAc

beta-L-thrHexpA4en-(1->4)-beta-D-GlcpNAc

C14H21NO12 (395.1064)


   

(2R,3R,4R)-2-[(2R,3R,4R,5R,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

(2R,3R,4R)-2-[(2R,3R,4R,5R,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO12 (395.1064)


   
   

[(2-{5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene}-1-hydroxy-2-phenylethylidene)amino]acetic acid

[(2-{5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene}-1-hydroxy-2-phenylethylidene)amino]acetic acid

C21H17NO7 (395.1005)


   

({2-[(4e,5e)-5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene]-1-hydroxy-2-phenylethylidene}amino)acetic acid

({2-[(4e,5e)-5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene]-1-hydroxy-2-phenylethylidene}amino)acetic acid

C21H17NO7 (395.1005)


   

({2-[(5e)-5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene]-1-hydroxy-2-phenylethylidene}amino)acetic acid

({2-[(5e)-5-[carboxy(phenyl)methylidene]-1,3-dioxolan-4-ylidene]-1-hydroxy-2-phenylethylidene}amino)acetic acid

C21H17NO7 (395.1005)


   

3-[(2,5-dihydroxy-3-methyl-1,4-benzodiazepin-3-yl)methyl]-2,3-dihydroxy-4,1-benzoxazepin-5-one

3-[(2,5-dihydroxy-3-methyl-1,4-benzodiazepin-3-yl)methyl]-2,3-dihydroxy-4,1-benzoxazepin-5-one

C20H17N3O6 (395.1117)


   

methyl 5-(6,7-dimethoxyisoquinoline-1-carbonyl)-2h-1,3-benzodioxole-4-carboxylate

methyl 5-(6,7-dimethoxyisoquinoline-1-carbonyl)-2h-1,3-benzodioxole-4-carboxylate

C21H17NO7 (395.1005)